Welcome to LookChem.com Sign In|Join Free
  • or
Phosphonium, [[4-(methylthio)phenyl]methyl]triphenyl-, chloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

58477-22-8

Post Buying Request

58477-22-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58477-22-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 58477-22-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,4,7 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 58477-22:
(7*5)+(6*8)+(5*4)+(4*7)+(3*7)+(2*2)+(1*2)=158
158 % 10 = 8
So 58477-22-8 is a valid CAS Registry Number.

58477-22-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (4-methylsulfanylphenyl)methyl-triphenylphosphanium,chloride

1.2 Other means of identification

Product number -
Other names p-Methylthiobenzyl-triphenylphosphoniumchlorid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58477-22-8 SDS

58477-22-8Upstream product

58477-22-8Relevant academic research and scientific papers

BISARYLCYCLOBUTENE DERIVATES AS CYCLOOXYGENASE INHIBITORS

-

, (2008/06/13)

The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).

Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors

-

, (2008/06/13)

The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising

Indenylidene-3-acetic acid process for preparing indene acetic acids

-

, (2008/06/13)

Process for preparing 5-fluoro-2-methyl-1-(p-methylsulfinylbenzylidene)-indene-3-acetic acid by reacting fluorobenzene with an acid halide, to form an indanone, reaction of the indanone with a methylthio (or methylsulfinyl)benzyl compound to form 5-fluoro-2-methyl-1-(p-methylthiobenzyl) or (p-methylsulfinylbenzyl)-indene and reacting said indene with a glyoxylic acid. The invention also relates to intermediates thereof and processes for said intermediates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 58477-22-8